Stellest Lens Wear in Adult Progressing Myopes

Launched by UNIVERSITY OF ULSTER · Jul 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of special glasses called Essilor Stellest lenses in slowing down the worsening of myopia (also known as nearsightedness) in adults aged 18 to 40. While many people think that myopia stabilizes in late teenage years, some adults continue to experience worsening vision. This trial aims to find out if these special lenses, designed for children, can also help adults manage their myopia more effectively.

To be eligible for the study, participants need to have a prescription for myopia that is less than -1.00D and have experienced noticeable worsening of their vision over the past two years. Individuals with significant eye conditions or those who have had previous treatments specifically for myopia management will not qualify. Participants can expect to wear the Stellest lenses while their vision is monitored over time, helping researchers gather important information on how these lenses may benefit adults with progressing myopia. The trial is currently recruiting participants, and everyone, regardless of gender, is welcome to apply.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Cycloplegic SER less than -0.75D
• • Astigmatism of 1.50D or less
• • Anisometropia of 1.50D or less
• • Evidence of annual progression of myopia of at least 0.50D in the previous two-year period
• Exclusion Criteria:
• • Previous myopia management (other than standard spectacle or contact lens correction)
• • Ocular and systemic diseases which might affect visual performance or myopia development